533 related articles for article (PubMed ID: 31936859)
1. Block-And-Lock Strategies to Cure HIV Infection.
Vansant G; Bruggemans A; Janssens J; Debyser Z
Viruses; 2020 Jan; 12(1):. PubMed ID: 31936859
[TBL] [Abstract][Full Text] [Related]
2. New latency-promoting agents for a block-and-lock functional cure strategy.
Pellaers E; Denis A; Debyser Z
Curr Opin HIV AIDS; 2024 May; 19(3):95-101. PubMed ID: 38457209
[TBL] [Abstract][Full Text] [Related]
3. Block and Lock HIV Cure Strategies to Control the Latent Reservoir.
Ahlenstiel CL; Symonds G; Kent SJ; Kelleher AD
Front Cell Infect Microbiol; 2020; 10():424. PubMed ID: 32923412
[TBL] [Abstract][Full Text] [Related]
4. Block-And-Lock: New Horizons for a Cure for HIV-1.
Moranguinho I; Valente ST
Viruses; 2020 Dec; 12(12):. PubMed ID: 33334019
[TBL] [Abstract][Full Text] [Related]
5. Barriers for HIV Cure: The Latent Reservoir.
Castro-Gonzalez S; Colomer-Lluch M; Serra-Moreno R
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):739-759. PubMed ID: 30056745
[TBL] [Abstract][Full Text] [Related]
6. Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure.
Duggan NN; Dragic T; Chanda SK; Pache L
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140676
[TBL] [Abstract][Full Text] [Related]
7. Targeting HIV-1 proviral transcription.
Olson A; Basukala B; Wong WW; Henderson AJ
Curr Opin Virol; 2019 Oct; 38():89-96. PubMed ID: 31473372
[TBL] [Abstract][Full Text] [Related]
8. Cure and Long-Term Remission Strategies.
Mori L; Valente ST
Methods Mol Biol; 2022; 2407():391-428. PubMed ID: 34985678
[TBL] [Abstract][Full Text] [Related]
9. Deep latency: A new insight into a functional HIV cure.
Elsheikh MM; Tang Y; Li D; Jiang G
EBioMedicine; 2019 Jul; 45():624-629. PubMed ID: 31227439
[TBL] [Abstract][Full Text] [Related]
10. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
[TBL] [Abstract][Full Text] [Related]
11. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy.
Schwarzer R; Gramatica A; Greene WC
Viruses; 2020 Feb; 12(2):. PubMed ID: 32046251
[TBL] [Abstract][Full Text] [Related]
12. Assays to Measure Latency, Reservoirs, and Reactivation.
Siliciano JD; Siliciano RF
Curr Top Microbiol Immunol; 2018; 417():23-41. PubMed ID: 29071475
[TBL] [Abstract][Full Text] [Related]
13. Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure.
Campbell GR; Spector SA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359967
[TBL] [Abstract][Full Text] [Related]
14. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
[TBL] [Abstract][Full Text] [Related]
15. Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection.
Debyser Z; Vansant G; Bruggemans A; Janssens J; Christ F
Viruses; 2018 Dec; 11(1):. PubMed ID: 30587760
[TBL] [Abstract][Full Text] [Related]
16. HIV "shock and kill" therapy: In need of revision.
Abner E; Jordan A
Antiviral Res; 2019 Jun; 166():19-34. PubMed ID: 30914265
[TBL] [Abstract][Full Text] [Related]
17. HIV cure strategies: which ones are appropriate for Africa?
Abana CZ; Lamptey H; Bonney EY; Kyei GB
Cell Mol Life Sci; 2022 Jul; 79(8):400. PubMed ID: 35794316
[TBL] [Abstract][Full Text] [Related]
18. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
Li C; Mori L; Valente ST
J Infect Dis; 2021 Feb; 223(12 Suppl 2):46-53. PubMed ID: 33586776
[TBL] [Abstract][Full Text] [Related]
19. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
[TBL] [Abstract][Full Text] [Related]
20. A New Small-Molecule Compound, Q308, Silences Latent HIV-1 Provirus by Suppressing Tat- and FACT-Mediated Transcription.
Zhou CL; Huang YF; Li YB; Liang TZ; Zheng TY; Chen P; Wu ZY; Lai FY; Liu SW; Xi BM; Li L
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0047021. PubMed ID: 34491808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
